Contrasting effects of filamin A and B proteins in modulating filovirus entry
-
Published:2023-08-16
Issue:8
Volume:19
Page:e1011595
-
ISSN:1553-7374
-
Container-title:PLOS Pathogens
-
language:en
-
Short-container-title:PLoS Pathog
Author:
Shepley-McTaggart Ariel,
Liang Jingjing,
Ding Yang,
Djurkovic Marija A.,
Kriachun Valeriia,
Shtanko Olena,
Sunyer Oriol,
Harty Ronald N.ORCID
Abstract
Ebola (EBOV) and Marburg viruses (MARV) cause severe hemorrhagic fever associated with high mortality rates in humans. A better understanding of filovirus-host interactions that regulate the EBOV and MARV lifecycles can provide biological and mechanistic insight critical for therapeutic development. EBOV glycoprotein (eGP) and MARV glycoprotein (mGP) mediate entry into host cells primarily by actin-dependent macropinocytosis. Here, we identified actin-binding cytoskeletal crosslinking proteins filamin A (FLNa) and B (FLNb) as important regulators of both EBOV and MARV entry. We found that entry of pseudotype psVSV-RFP-eGP, infectious recombinant rVSV-eGP-mCherry, and live authentic EBOV and MARV was inhibited in filamin A knockdown (FLNaKD) cells, but was surprisingly enhanced in filamin B knockdown (FLNbKD) cells. Mechanistically, our findings suggest that differential regulation of macropinocytosis by FLNa and FLNb likely contributes to their specific effects on EBOV and MARV entry. This study is the first to identify the filamin family of proteins as regulators of EBOV and MARV entry. These findings may provide insight into the development of new countermeasures to prevent EBOV and MARV infections.
Funder
National Institute of Allergy and Infectious Diseases
National Eye Institute
Texas Biomedical Research Institute
Publisher
Public Library of Science (PLoS)
Subject
Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology
Reference56 articles.
1. World Health Organization: Ebola virus disease Available online: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON398 [
2. Ebola virus disease;D Malvy;The Lancet,2019
3. Ebola Virus Disease: Epidemiology, Clinical Features, Management, and Prevention;E Nicastri;Infect Dis Clin North Am,2019
4. Exotic emerging viral diseases: progress and challenges;TW Geisbert;Nat Med,2004
5. CDC. Bioterrorism Agents/Diseases. https://emergencycdcgov/agent/agentlist-categoryasp.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献